Download
00467_2024_Article_6459.pdf 697,11KB
WeightNameValue
1000 Titel
  • Factors influencing circuit lifetime in paediatric continuous kidney replacement therapies – results from the EurAKId registry
1000 Autor/in
  1. Deja, Anna |
  2. Guzzo, Isabella |
  3. Cappoli, Andrea |
  4. Labbadia, Raffaella |
  5. Bayazit, Aysun Karabay |
  6. Yildizdas, Dincer |
  7. Schmitt, Claus Peter |
  8. Tkaczyk, Marcin |
  9. Cvetkovic, Mirjana |
  10. Kostic, Mirjana |
  11. Hayes, Wesley |
  12. Shroff, Rukshana |
  13. Jankauskiene, Augustina |
  14. Virsilas, Ernestas |
  15. Longo, Germana |
  16. Vidal, Enrico |
  17. Mir, Sevgi |
  18. Bulut, Ipek Kaplan |
  19. Pasini, Andrea |
  20. Paglialonga, Fabio |
  21. Montini, Giovanni |
  22. Yilmaz, Ebru |
  23. Correia Costa, Liane |
  24. Teixeira, Ana |
  25. Schaefer, Franz |
  26. for the ESCAPE Network |
1000 Verlag Springer Berlin Heidelberg
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-07-18
1000 Erschienen in
1000 Quellenangabe
  • 39(11):3353-3362
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00467-024-06459-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413113/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>Continuous kidney replacement therapy (CKRT) has recently become the preferred kidney replacement modality for children with acute kidney injury (AKI). We hypothesise that CKRT technical parameters and treatment settings in addition to the clinical characteristics of patients may influence the circuit lifetime in children.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>The study involved children included in the EurAKId registry (NCT 02960867), who underwent CKRT treatment. We analysed patient characteristics and CKRT parameters. The primary end point was mean circuit lifetime (MCL). Secondary end points were number of elective circuit changes and occurrence of dialysis-related complications.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>The analysis was composed of 247 children who underwent 37,562 h of CKRT (median 78, IQR 37–165 h per patient). A total of 1357 circuits were utilised (3, IQR 2–6 per patient). MCL was longer in regional citrate anticoagulation (RCA), compared to heparin (HA) and no anticoagulation (NA) (42, IQR 32-58 h; 24, IQR 14-34 h; 18, IQR 12-24 h, respectively, p &lt; 0.001). RCA was associated with longer MCL regardless of the patient’s age or dialyser surface. In multivariate analysis, MCL correlated with dialyser surface area (beta = 0.14, p = 0.016), left internal jugular vein vascular access site (beta = -0.37, p = 0.027), and the use of HA (beta = -0.14, p = 0.038) or NA (beta = -0.37, p &lt; 0.001) vs. RCA. RCA was associated with the highest ratio of elective circuit changes and the lowest incidence of complications.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>Anticoagulation modality, dialyser surface, and vascular access site influence MCL. RCA should be considered when choosing first-line anticoagulation for CKRT in children. Further efforts should focus on developing guidelines and clinical practice recommendations for paediatric CKRT.</jats:p> </jats:sec><jats:sec> <jats:title>Graphical abstract</jats:title> </jats:sec>
1000 Sacherschließung
lokal Anticoagulants/administration
lokal Continuous Renal Replacement Therapy/methods [MeSH]
lokal Original Article
lokal Infant [MeSH]
lokal Male [MeSH]
lokal Acute Kidney Injury/etiology [MeSH]
lokal Registries/statistics
lokal Continuous Renal Replacement Therapy/statistics
lokal Child [MeSH]
lokal Acute Kidney Injury/therapy [MeSH]
lokal Female [MeSH]
lokal Anticoagulants/adverse effects [MeSH]
lokal Acute Kidney Injury/epidemiology [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Circuit lifetime
lokal Treatment Outcome [MeSH]
lokal Continuous Renal Replacement Therapy/instrumentation [MeSH]
lokal Regional citrate anticoagulation
lokal What's New in Dialysis
lokal Acute kidney injury
lokal Continuous kidney replacement therapy
lokal Time Factors [MeSH]
lokal Heparin/administration
lokal Anticoagulants/therapeutic use [MeSH]
lokal Child, Preschool [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-9901-4140|https://frl.publisso.de/adhoc/uri/R3V6em8sIElzYWJlbGxh|https://frl.publisso.de/adhoc/uri/Q2FwcG9saSwgQW5kcmVh|https://frl.publisso.de/adhoc/uri/TGFiYmFkaWEsIFJhZmZhZWxsYQ==|https://frl.publisso.de/adhoc/uri/QmF5YXppdCwgQXlzdW4gS2FyYWJheQ==|https://frl.publisso.de/adhoc/uri/WWlsZGl6ZGFzLCBEaW5jZXI=|https://frl.publisso.de/adhoc/uri/U2NobWl0dCwgQ2xhdXMgUGV0ZXI=|https://frl.publisso.de/adhoc/uri/VGthY3p5aywgTWFyY2lu|https://frl.publisso.de/adhoc/uri/Q3ZldGtvdmljLCBNaXJqYW5h|https://frl.publisso.de/adhoc/uri/S29zdGljLCBNaXJqYW5h|https://frl.publisso.de/adhoc/uri/SGF5ZXMsIFdlc2xleQ==|https://frl.publisso.de/adhoc/uri/U2hyb2ZmLCBSdWtzaGFuYQ==|https://frl.publisso.de/adhoc/uri/SmFua2F1c2tpZW5lLCBBdWd1c3RpbmE=|https://frl.publisso.de/adhoc/uri/Vmlyc2lsYXMsIEVybmVzdGFz|https://frl.publisso.de/adhoc/uri/TG9uZ28sIEdlcm1hbmE=|https://frl.publisso.de/adhoc/uri/VmlkYWwsIEVucmljbw==|https://frl.publisso.de/adhoc/uri/TWlyLCBTZXZnaQ==|https://frl.publisso.de/adhoc/uri/QnVsdXQsIElwZWsgS2FwbGFu|https://frl.publisso.de/adhoc/uri/UGFzaW5pLCBBbmRyZWE=|https://frl.publisso.de/adhoc/uri/UGFnbGlhbG9uZ2EsIEZhYmlv|https://frl.publisso.de/adhoc/uri/TW9udGluaSwgR2lvdmFubmk=|https://frl.publisso.de/adhoc/uri/WWlsbWF6LCBFYnJ1|https://frl.publisso.de/adhoc/uri/Q29ycmVpYSBDb3N0YSwgTGlhbmU=|https://frl.publisso.de/adhoc/uri/VGVpeGVpcmEsIEFuYQ==|https://frl.publisso.de/adhoc/uri/U2NoYWVmZXIsIEZyYW56|https://frl.publisso.de/adhoc/uri/Zm9yIHRoZSBFU0NBUEUgTmV0d29yaw==
1000 Hinweis
  • DeepGreen-ID: 9cf12bbbb5ad42d686541148db2a2827 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search) ;
1000 Label
1000 Förderer
  1. Baxter Healthcare Corporation |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Baxter Healthcare Corporation |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6521687.rdf
1000 Erstellt am 2025-07-06T09:37:02.179+0200
1000 Erstellt von 322
1000 beschreibt frl:6521687
1000 Zuletzt bearbeitet 2025-08-04T08:54:57.932+0200
1000 Objekt bearb. Mon Aug 04 08:54:57 CEST 2025
1000 Vgl. frl:6521687
1000 Oai Id
  1. oai:frl.publisso.de:frl:6521687 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source